语音生物标志物如何被用于心力衰竭管理:一个范围审查
Yufan Yang1, Mo Chen2, Shuyu Han1
1School of Nursing, Peking University, Beijing, China.
Current medical research and opinion
|November 6, 2025
概括
语音生物标志物为治疗心力衰竭提供了一种非侵入性方法. 这次审查发现语音/语音分析显示了诊断和监测的潜力,但需要标准化用于临床使用.
科学领域:
- 生物医学工程 生物医学工程
- 心脏病学 心脏病学
- 数字健康数字健康
背景情况:
- 语音生物标志物越来越多地用于非侵入性疾病诊断和监测.
- 它们的低成本和可访问性使得它们对临床应用具有吸引力.
研究的目的:
- 进行范围审查,总结关于心力衰竭管理中的语音生物标志物的证据.
- 在这种情况下描述用于收集,处理和分析语音数据的方法.
主要方法:
- 从开始到2024年1月10日,搜索了四个数据库 (PubMed,CINAHL,Scopus,IEEE Xplore) 从开始到2024年1月10日.
- 遵循乔安娜·布里格斯研究所的框架和PRISMA-ScR指南.
- 包括2010年至2023年间发表的19项研究.
主要成果:
- 语音生物标志物用于诊断 (9/19) 和疾病监测 (10/19).
- 语音/言语是常见的生物标志物,通过麦克风,手机或应用程序收集.
- 常见的处理涉及细分,特征提取,denoising和重新采样;大多数研究都开发了新的算法.
- 用准确性,灵敏性和特异性来评估模型性能.
结论:
- 语音/语音生物标志物显示出心力衰竭管理的巨大潜力.
- 它们的非侵入性和可访问性支持将其纳入临床监测.
- 数据收集,处理和分析的标准化程序对于可靠的临床应用至关重要.
更多相关视频
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
517
03:47Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
1.1K
相关概念视频
Heart Failure V: Medical Management
207
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
207
Heart Failure VII: Nursing Interventions
404
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
404
Heart Failure IV: Classification and Diagnostic Evaluation
305
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
305
Heart Failure I: Introduction
671
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
671
Heart Failure Drugs: β-Blockers
747
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
747
Heart Failure III: Clinical Manifestations
457
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
457
